Statement Of Cash Flows [Abstract]

Redcare Pharmacy N.V. - Filing #5831390

Concept 2023-12-31 to
2024-12-31
2022-12-31 to
2023-12-31
Statement of cash flows [abstract]
Cash flows from (used in) operating activities [abstract]
Cash flows from (used in) operations before changes in working capital
32,317,000 EUR
47,963,000 EUR
Increase (decrease) in working capital
10,191,000 EUR
13,493,000 EUR
Adjustments for decrease (increase) in trade and other receivables
8,019,000 EUR
20,316,000 EUR
Adjustments for increase (decrease) in trade and other payables
25,080,000 EUR
56,814,000 EUR
Cash flows from (used in) investing activities [abstract]
Dividends received from associates, classified as investing activities
122,000 EUR
190,000 EUR
Proceeds from sales or maturity of financial instruments, classified as investing activities
40,000,000 EUR
33,761,000 EUR
Cash flows from (used in) financing activities [abstract]
Dividends paid to non-controlling interests, classified as financing activities
3,058,000 EUR
1,666,000 EUR
Proceeds from exercise of options
3,966,000 EUR
2,646,000 EUR
Repayments of non-current borrowings
1,625,000 EUR
0 EUR

Talk to a Data Expert

Have a question? We'll get back to you promptly.